Table 3 Exposed penile length comparison in relative and percentage value [(Longer-Shorter)/Shorter].
From: HCG supplement did not accelerate tunica albuginea remodeling to facilitate penile growth
Exposed penile length | Control | Anti-LOX | HCG | VED | Anti-LOX + VED | HCG + VED |
|---|---|---|---|---|---|---|
Anti-LOX (mm, %) | 2.42 (9%) | – | – | – | – | – |
HCG (mm, %) | 0.75 (3%) | 2.42 (9%) | – | – | – | – |
VED (mm, %) | 2.67 (9%) | 0.25 (1%) | 2.67 (9%) | – | – | – |
Anti-LOX + VED (mm, %) | 5.33 (19%) | 2.92 (10%) | 5.33 (19%) | 2.67 (9%) | – | – |
HCG + VED (mm, %) | 3.08 (11%) | 0.67 (2%) | 3.08 (11%) | 0.42 (1%) | 2.25 (7%) | – |
Anti-LOX + HCG + VED (mm, %) | 5.17 (18%) | 2.75 (9%) | 5.17 (18%) | 2.50 (8%) | 0.17 (1%) | 2.08 (7%) |
